Lifestyle and severe SARS-CoV-2 infections: Does the individual metabolic burden determines the outcome?
作者信息
Markus Birgit, Kreutz Julian, Schieffer Bernhard
机构信息
Department of Cardiology, Angiology and Intensive Care Medicine, Philipps University of Marburg, University Hospital (UKGM), Marburg, Germany.
出版信息
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320963929. doi: 10.1177/1470320320963929.
Abstract
摘要
相似文献
1
Lifestyle and severe SARS-CoV-2 infections: Does the individual metabolic burden determines the outcome?生活方式与严重的新冠病毒感染：个体的代谢负担会决定结果吗？
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320963929. doi: 10.1177/1470320320963929.
2
Relative Limited Impact of COVID-19 on Diabetes: A Personal View.新冠病毒病对糖尿病的相对有限影响：个人观点
J Diabetes Sci Technol. 2020 Jul;14(4):727-728. doi: 10.1177/1932296820930270. Epub 2020 May 29.
3
COVID-19, chronic inflammatory respiratory diseases and eosinophils-Observations from reported clinical case series.2019冠状病毒病、慢性炎症性呼吸道疾病与嗜酸性粒细胞——来自已报告临床病例系列的观察结果
Allergy. 2020 Jul;75(7):1819-1822. doi: 10.1111/all.14353.
4
SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.SARS-CoV-2 扰乱肾素-血管紧张素系统和能量代谢。
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E43-E47. doi: 10.1152/ajpendo.00219.2020. Epub 2020 May 29.
5
COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.2019冠状病毒病：糖尿病与心血管疾病管理的考量
J Diabetes Sci Technol. 2020 Jul;14(4):723-724. doi: 10.1177/1932296820930025. Epub 2020 May 30.
6
COVID-19 and obesity: links and risks.2019冠状病毒病与肥胖：关联及风险
Expert Rev Endocrinol Metab. 2020 Jul;15(4):215-216. doi: 10.1080/17446651.2020.1767589. Epub 2020 May 22.
7
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.ACE2：作为 SARS-CoV-2 进入受体的证据及其在合并症中的意义。
Elife. 2020 Nov 9;9:e61390. doi: 10.7554/eLife.61390.
8
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB.COVID-19 感染患者服用 ACEI/ARB 的结果。
Curr Cardiol Rep. 2020 Apr 14;22(5):31. doi: 10.1007/s11886-020-01291-4.
9
COVID-19: The heart of the issue.新冠病毒：问题的核心。
J Card Surg. 2020 Aug;35(8):2112. doi: 10.1111/jocs.14684. Epub 2020 Jun 16.
10
Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.新型冠状病毒肺炎的合并症：高血压患者队列的结局以及肾素-血管紧张素系统阻滞剂引发的争议
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):283-287. doi: 10.1016/j.dsx.2020.03.016. Epub 2020 Apr 9.
本文引用的文献
1
Air pollution and COVID-19 mortality in the United States: Strengths and limitations of an ecological regression analysis.空气污染与美国新冠肺炎死亡率：生态回归分析的优势与局限
Sci Adv. 2020 Nov 4;6(45). doi: 10.1126/sciadv.abd4049. Print 2020 Nov.
2
Obesity aggravates COVID-19: A systematic review and meta-analysis.肥胖加剧 COVID-19：系统评价和荟萃分析。
J Med Virol. 2021 Jan;93(1):257-261. doi: 10.1002/jmv.26237. Epub 2020 Oct 5.
3
Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity.导致肥胖人群对COVID-19易感性增加和病情加重的潜在病理生理机制。
Obes Med. 2020 Sep;19:100259. doi: 10.1016/j.obmed.2020.100259. Epub 2020 May 26.
4
COVID-19 and hypertension.新型冠状病毒肺炎与高血压
J Renin Angiotensin Aldosterone Syst. 2020 Apr-Jun;21(2):1470320320927851. doi: 10.1177/1470320320927851.
5
Dietary habits in adults during quarantine in the context of COVID-19 pandemic.新冠疫情背景下成年人在隔离期间的饮食习惯
Obes Med. 2020 Sep;19:100254. doi: 10.1016/j.obmed.2020.100254. Epub 2020 May 15.
6
Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization: a proposal for early insulin therapy.2型糖尿病合并冠状病毒病患者住院期间的血糖控制：早期胰岛素治疗建议
Am J Physiol Endocrinol Metab. 2020 Jun 1;318(6):E835-E837. doi: 10.1152/ajpendo.00163.2020.
7
COVID-19 pandemic: the effects of quarantine on cardiovascular risk.COVID-19 大流行：隔离对心血管风险的影响。
Eur J Clin Nutr. 2020 Jun;74(6):852-855. doi: 10.1038/s41430-020-0646-z. Epub 2020 May 5.
8
COVID-19 pandemic, coronaviruses, and diabetes mellitus.COVID-19 大流行、冠状病毒和糖尿病。
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741. doi: 10.1152/ajpendo.00124.2020. Epub 2020 Mar 31.
9
Renin-angiotensin system in human coronavirus pathogenesis.人类冠状病毒发病机制中的肾素-血管紧张素系统。
Future Virol. 2010 Mar;5(2):145-161. doi: 10.2217/fvl.10.4. Epub 2010 Mar 1.
10
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.合并症的患病率及其对 SARS-CoV-2 感染患者的影响：系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
Zotero 插件